{
    "id": "0125",
    "question": "A 33-year-old nurse is referred to an infectious disease specialist after she exhibited a PPD skin test with 17 mm of induration. She denies any cough, shortness of breath, hemoptysis, weight loss, fatigue, fevers, or night sweats over the last several months. Her temperature is 97.0\u00b0F (36.1\u00b0C), blood pressure is 120/81 mmHg, pulse is 82/min, respirations are 15/min, and oxygen saturation is 98% on room air. An initial chest radiograph is unremarkable. Which of the following is the most appropriate management of this patient?",
    "options": {
        "A": "Isoniazid",
        "B": "No management indicated",
        "C": "Repeat PPD in 1 week",
        "D": "Rifampin, isoniazid, pyrazinamide, and ethambutol"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To determine the most appropriate management for this patient, let's analyze the given information step by step. 1. The patient is a 33-year-old nurse who has tested positive for a PPD (Purified Protein Derivative) skin test with 17 mm of induration. This indicates a positive reaction to the tuberculin test, which is a common screening test for latent tuberculosis (TB). 2. The patient denies any symptoms such as cough, shortness of breath, hemoptysis, weight loss, fatigue, fevers, or night sweats over the last several months. This suggests that she may have latent TB, as the symptoms of active TB are not present. 3. Her vital signs are within normal limits, with a temperature of 97.0\u00b0F (36.1\u00b0C), blood pressure of 120/81 mmHg, pulse of 82/min, respirations of 15/min, and oxygen saturation of 98% on room air. These findings further support the possibility of latent TB. 4. The initial chest radiograph is unremarkable, which means that there are no abnormalities in the lungs that would suggest active TB. 5. Considering the patient's positive PPD test result and the absence of symptoms or radiographic evidence of active TB, the Centers for Disease Control and Prevention (CDC) guidelines recommend that individuals with a positive PPD test and no symptoms of active TB be treated for latent TB infection. 6. The CDC recommends that latent TB infection be treated with isoniazid (INH) for 9 months. The other options listed, such as rifampin, isoniazid, pyrazinamide, and ethambutol, are typically used to treat active TB, not latent TB. Therefore, the most appropriate management for this patient is isoniazid (INH) for 9 months, but since the option does not explicitly mention the duration, we can infer that the correct answer is A. Isoniazid.\"} \"answer_choice\": \"A\"",
    "snippets": [],
    "scores": [],
    "execution_time": 11.932484865188599
}